52

Ishita Drugs and Industries LtdBOM 524400

Последний отчетный период 30 сент., 2023

Обновлено 20 сент., 2024

Последняя цена

Капитализация млрд. $

0.002

Micro

Биржа

XBOM - Bombay Stock Exchange

Анализ акций 524400.BO

52

Нет оценки

Количественный анализ Eyestock не покрывает акции Ishita Drugs and Industries Ltd.

Капитализация млрд. $

0.002

Дивидендная доходность

Оборот

2.99 млрд

Сайт компании

https://www.ishitadrugs.com/

Ishita Drugs & Industries Ltd. engages in the manufacturing of basic drugs. The company is headquartered in Ahmedabad, Gujarat. The firm's APIs include sulpha drugs/sulfonamides, vitamins, fluoroquinolones, antibiotics, anthelmintics, iodides and citrates (salts), food additive/excipients, and others. Its drug intermediates include 4- Sulfonamido Phenyl Hydrazine Hydrochloride (Celecoxib Intermediate), 4- Chloro Phenyl Hydrazine Hydrochloride (intermediate for Indole Carboxylic Acid), L-Alanine Benzylester Tosylate, 5 Cyano Phthalide (Citalopram Intermediate), Indole 2 Carboxylic Acid, Ethyl 3-Benzoyl Acrylate, Hexa Methyl Disilazane, 5-Chloromethopabate, Indole 2 Carboxylic Acid, and others. Its fine chemicals include salicylanilide, para bromo toluene, pyridine hydrobromide, potassium phthalimide, nicotinic acid hydrazide, 3 amino pyridine, methyl iodide. Its products are exported to various countries across the world.

Смотреть Секцию: Рейтинг